These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3432136)

  • 61. Effects of central injection of kyotorphin and L-arginine on oxytocin and vasopressin release and blood pressure in conscious rats.
    Summy-Long JY; Bui V; Gestl S; Koehler-Stec E; Liu H; Terrell ML; Kadekaro M
    Brain Res Bull; 1998; 45(4):395-403. PubMed ID: 9527014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB.
    Giralt MT; Bonanno G; Raiteri M
    Eur J Pharmacol; 1990 Jan; 175(2):137-44. PubMed ID: 2155793
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine.
    Watson CJ; Lydic R; Baghdoyan HA
    Neuroscience; 2007 Jan; 144(1):375-86. PubMed ID: 17055662
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulation of synaptosomal GABA release by enkephalin.
    Brennan MJ; Cantrill RC; Wylie BA
    Life Sci; 1980 Sep; 27(12):1097-101. PubMed ID: 7421401
    [No Abstract]   [Full Text] [Related]  

  • 65. Stimulation of [3H]gamma-aminobutyric acid release by calcium chelators in synaptosomes.
    Arias C; Sitges M; Tapia R
    J Neurochem; 1984 Jun; 42(6):1507-14. PubMed ID: 6144725
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The stinging response of the honeybee: effects of morphine, naloxone and some opioid peptides.
    Núñez J; Maldonado H; Miralto A; Balderrama N
    Pharmacol Biochem Behav; 1983 Dec; 19(16):921-4. PubMed ID: 6657718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.
    Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A
    Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The role of the brain serotoninergic system in the mechanisms of the effect of kyotorphin on animal behavior].
    Semenova TP; Medvinskaia NI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(1):170-2. PubMed ID: 8693783
    [No Abstract]   [Full Text] [Related]  

  • 69. Implication of endogenous opioid mechanism in the production of the antinociceptive effect induced by psychological stress in mice.
    Takahashi M; Tokuyama S; Kaneto H
    Jpn J Pharmacol; 1987 Jul; 44(3):283-91. PubMed ID: 2821308
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Uptake and release of kyotorphin in rat brain synaptosomes.
    Ueda H; Matsumoto S; Yoshihara Y; Fukushima N; Takagi H
    Life Sci; 1986 Jun; 38(26):2405-11. PubMed ID: 3724363
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline.
    Sweeney MI; White TD; Sawynok J
    J Pharmacol Exp Ther; 1987 Nov; 243(2):657-65. PubMed ID: 2824755
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of opioid and GABA systems in the ventrolateral periaqueductal gray on analgesia associated with tonic immobility.
    Miranda-Páez A; Zamudio S; Vázquez-León P; Campos-Rodríguez C; Ramírez-San Juan E
    Pharmacol Biochem Behav; 2016 Mar; 142():72-8. PubMed ID: 26780595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Involvement of GABAergic modulation of the nucleus submedius (Sm) morphine-induced antinociception.
    Jia H; Xie YF; Xiao DQ; Tang JS
    Pain; 2004 Mar; 108(1-2):28-35. PubMed ID: 15109504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Release-regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain.
    Bonanno G; Raiteri M
    Synapse; 1987; 1(3):254-7. PubMed ID: 2850623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gamma-aminobutyric acidA (GABAA) receptor modulation of morphine inhibition of norepinephrine release.
    Peoples RW; Giridhar J; Isom GE
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S121-6. PubMed ID: 1662949
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice.
    Ochi T; Ohkubo Y; Mutoh S
    Neurosci Lett; 2002 Apr; 322(2):95-8. PubMed ID: 11958852
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Kyotorphin (tyrosine-arginine): further evidence for indirect opiate receptor activation.
    Rackham A; Wood PL; Hudgin RL
    Life Sci; 1982 Apr; 30(16):1337-42. PubMed ID: 6283289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effects of acute and chronic morphine administration on GABA receptor binding.
    Ticku MK; Huffman RD
    Eur J Pharmacol; 1980 Nov; 68(2):97-106. PubMed ID: 6258932
    [TBL] [Abstract][Full Text] [Related]  

  • 80. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
    Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
    J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.